# Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma

> **NCT06551272** · PHASE2 · RECRUITING · sponsor: **Center Eugene Marquis** · enrollment: 34 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** EXL01

## Key facts

- **NCT ID:** NCT06551272
- **Lead sponsor:** Center Eugene Marquis
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-12
- **Primary completion:** 2026-03-12
- **Final completion:** 2026-12-12
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06551272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06551272, "Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06551272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*